Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Lincoln, USA
16 Conant Road
Lincoln, MA, 01773
USA

Funding

Tags

Cydan

Cydan is an orphan drug accelerator that identifies and de-risks compounds with therapeutic and commercial potential. Their rigorous process generates data to support a development path and new company formation. Cydan’s experienced and globally networked team brings strong relationships with academia and patient advocacy, deep expertise in drug development, and a track record of successful product commercialization.

Recent Milestones

  • Dollar
    Cydan received $10M in Venture Round funding. (10/1/13)
    Posted 10/1/13 at 5:13am via finsmes.com
  • Dollar
    Cydan received $16M in Venture Round funding. (4/11/13)
    Posted 4/12/13 at 4:59am via businesswire.com

Videos

Screenshots

Cydan screenshot
Above: Cydan
Uploaded: 4/12/13

Sources

  1. Cydan, a New Orphan Drug Accelerator, Launches with $16 Million Financing from Leading Investors NEA, Pfizer Venture Investments and Alexandria Real Estate Equities (businesswire.com) [edit]
  2. Cydan Raises $10M Funding (finsmes.com) [edit]
Edit This Page
Last Edited 3/28/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy